NDC properties for NDC 9 0378-0266
NDC item 00378026691
| NDC 9 | 0378-0266 |
|---|---|
| NDC 10 | 0378-0266-91 |
| NDC Item | 00378026691 |
| packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0266-91) |
| ANDA | ANDA208067 |
| COLORTEXT | PURPLE(light purple opaque),WHITE(white opaque) |
| Color | C48327;C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;150 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 00378026693
| NDC 9 | 0378-0266 |
|---|---|
| NDC 10 | 0378-0266-93 |
| NDC Item | 00378026693 |
| packaging | 30 in 1 BOTTLE, PLASTIC |
| ANDA | ANDA208067 |
| COLORTEXT | PURPLE(light purple opaque),WHITE(white opaque) |
| Color | C48327;C48325 __ |
| FDA SPL set id | 862787 |
| Imprint code | MYLAN;DE;150 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-25 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 31722062231
| NDC 9 | 31722-622 |
|---|---|
| NDC 10 | 31722-622-31 |
| NDC Item | 31722062231 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D11 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 31722062232
| NDC 9 | 31722-622 |
|---|---|
| NDC 10 | 31722-622-32 |
| NDC Item | 31722062232 |
| packaging | 10 BLISTER PACK in 1 CARTON (31722-622-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D11 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 31722062260
| NDC 9 | 31722-622 |
|---|---|
| NDC 10 | 31722-622-60 |
| NDC Item | 31722062260 |
| packaging | 60 CAPSULE in 1 BOTTLE (31722-622-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 859548 |
| Imprint code | H;D11 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-05-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 42291003460
| NDC 9 | 42291-034 |
|---|---|
| NDC 10 | 42291-034-60 |
| NDC Item | 42291003460 |
| packaging | 60 CAPSULE in 1 BOTTLE (42291-034-60) |
| ANDA | ANDA213879 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 836394 |
| Imprint code | MD;150 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-11-27 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 43598064160
| NDC 9 | 43598-641 |
|---|---|
| NDC 10 | 43598-641-60 |
| NDC Item | 43598064160 |
| packaging | 60 CAPSULE in 1 BOTTLE (43598-641-60) |
| ANDA | ANDA208048 |
| COLORTEXT | WHITE(white opaque cap),WHITE(white opaque body) |
| Color | C48325;C48325 __ |
| FDA SPL set id | 862457 |
| Imprint code | 150 |
| Labeler | Dr.Reddys Laboratories Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 46708063606
| NDC 9 | 46708-636 |
|---|---|
| NDC 10 | 46708-636-06 |
| NDC Item | 46708063606 |
| packaging | 10 BLISTER PACK in 1 CARTON (46708-636-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque),WHITE(White opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;316 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
NDC item 46708063660
| NDC 9 | 46708-636 |
|---|---|
| NDC 10 | 46708-636-60 |
| NDC Item | 46708063660 |
| packaging | 60 CAPSULE in 1 BOTTLE (46708-636-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque),WHITE(White opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;316 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
NDC item 50090753000
| NDC 9 | 50090-7530 |
|---|---|
| NDC 10 | 50090-7530-0 |
| NDC Item | 50090753000 |
| packaging | 60 CAPSULE in 1 BOTTLE (50090-7530-0) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 870701 |
| Imprint code | MD;150 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 60505434806
| NDC 9 | 60505-4348 |
|---|---|
| NDC 10 | 60505-4348-6 |
| NDC Item | 60505434806 |
| packaging | 60 CAPSULE in 1 BOTTLE (60505-4348-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 870185 |
| Imprint code | APO;D150 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 60687075232
| NDC 9 | 60687-752 |
|---|---|
| NDC 10 | 60687-752-32 |
| NDC Item | 60687075232 |
| packaging | 20 BLISTER PACK in 1 CARTON (60687-752-32) / 1 CAPSULE in 1 BLISTER PACK (60687-752-33) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D11 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 60687075233
| NDC 9 | 60687-752 |
|---|---|
| NDC 10 | 60687-752-33 |
| NDC Item | 60687075233 |
| packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap / cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 822867 |
| Imprint code | H;D11 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 62332063606
| NDC 9 | 62332-636 |
|---|---|
| NDC 10 | 62332-636-06 |
| NDC Item | 62332063606 |
| packaging | 10 BLISTER PACK in 1 CARTON (62332-636-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque),WHITE(White opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;316 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
NDC item 62332063660
| NDC 9 | 62332-636 |
|---|---|
| NDC 10 | 62332-636-60 |
| NDC Item | 62332063660 |
| packaging | 60 CAPSULE in 1 BOTTLE (62332-636-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque),WHITE(White opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;316 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-14 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
NDC item 67877047560
| NDC 9 | 67877-475 |
|---|---|
| NDC 10 | 67877-475-60 |
| NDC Item | 67877047560 |
| packaging | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-475-60) |
| ANDA | ANDA208040 |
| COLORTEXT | BLUE(Light navy blue opaque),WHITE(Light cream opaque) |
| Color | C48333;C48325 __ |
| FDA SPL set id | 816153 |
| Imprint code | DAB;150 |
| Labeler | Ascend Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-20 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 23 mm |
NDC item 72205020434
| NDC 9 | 72205-204 |
|---|---|
| NDC 10 | 72205-204-34 |
| NDC Item | 72205020434 |
| packaging | 6 BLISTER PACK in 1 CARTON (72205-204-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;150 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 72205020460
| NDC 9 | 72205-204 |
|---|---|
| NDC 10 | 72205-204-60 |
| NDC Item | 72205020460 |
| packaging | 60 CAPSULE in 1 BOTTLE (72205-204-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;150 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-22 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
NDC item 72865027360
| NDC 9 | 72865-273 |
|---|---|
| NDC 10 | 72865-273-60 |
| NDC Item | 72865027360 |
| packaging | 60 CAPSULE in 1 BOTTLE (72865-273-60) |
| ANDA | ANDA207961 |
| COLORTEXT | blue(light blue opaque cap and cream opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 774027 |
| Imprint code | H;D11 |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |